What is the maximum recommended dose of venlafaxine (Effexor) Extended Release (ER)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Venlafaxine ER

The maximum dose of venlafaxine ER is 375 mg/day, though routine outpatient depression typically requires no more than 225 mg/day. 1

Standard Maximum Dosing

  • The FDA-approved maximum dose is 375 mg/day for severe depression, typically administered in divided doses. 1
  • For routine outpatient depression, doses above 225 mg/day showed no additional benefit in clinical trials, making 225 mg/day the practical maximum for most patients. 1
  • More severely depressed inpatients may require higher doses up to the 375 mg/day maximum, with historical data showing inpatients responding to mean doses of 350 mg/day. 1

Dose Escalation Strategy

  • Start at 37.5 mg once or twice daily, then increase by 75 mg increments weekly as tolerated. 2
  • The target therapeutic range is 150-225 mg/day for most indications including depression and neuropathic pain. 2, 3
  • When increasing doses, increments of up to 75 mg/day should be made at intervals of no less than 4 days. 1

Critical Safety Monitoring at Higher Doses

  • Blood pressure monitoring becomes mandatory at doses exceeding 150 mg/day due to dose-dependent hypertension risk. 2, 3
  • The incidence of sustained blood pressure elevation increases significantly with dose: 3-5% at ≤200 mg/day, 7% at 201-300 mg/day, and 13% at >300 mg/day (versus 2% with placebo). 4
  • Venlafaxine should be prescribed with caution in patients with pre-existing cardiac disease, particularly at higher doses. 2

Tolerability Considerations

  • Higher doses (≥375 mg/day) are tolerated but associated with increased frequency and severity of side effects including constipation, sweating, hypertension, agitation, and urinary frequency. 5, 6
  • Nausea is the most common dose-dependent side effect and the leading cause of discontinuation, though it typically resolves within 1-3 weeks. 2, 4
  • Despite increased side effects at higher doses, discontinuation rates remain comparable to standard dosing in clinical practice. 5

Special Population Adjustments

  • Hepatic impairment (mild to moderate): Reduce total daily dose by 50%. 1
  • Renal impairment (GFR 10-70 mL/min): Reduce total daily dose by 25%. 1
  • Hemodialysis patients: Reduce total daily dose by 50%. 1
  • Elderly patients require no dose adjustment based on age alone, though extra caution is warranted when increasing doses. 1

Discontinuation Protocol

  • Always taper venlafaxine gradually over 10-14 days; never discontinue abruptly due to well-documented withdrawal syndrome risk. 2, 3
  • If intolerable withdrawal symptoms occur, resume the previous dose and taper more gradually. 1

References

Guideline

Venlafaxine ER Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dose-Response Relationship and Safety Considerations for Venlafaxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of venlafaxine in rational antidepressant therapy.

The Journal of clinical psychiatry, 1994

Research

Tolerability of high-dose venlafaxine in depressed patients.

Journal of psychopharmacology (Oxford, England), 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.